amiD Resolved · high auto-curated

H37Rv Rv3375 · MTBC0 mtbc0_003590 · 475 aa · 3815338–3816765 MTBC0 (+) · RefSeq NP_217892.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)amidase
MTBC0 PGAP re-annotationamidase
Revised (this work)Amidase. Pfam: Amidase (PF01425.27).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 83 publications

83 TB publications mention this gene. 83 publications discuss this gene. Queried separately, 79 records carry a M. tuberculosis context and 10 a non-TB mycobacterial context (species named in the 10-record verified sample: M. smegmatis (6), M. abscessus (3), M. marinum (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 83: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Prioritising communicable disease research in Afghanistan: an application of the Child Health and Nutrition Research Initiative (CHNRI) methodology. doi:10.1136/bmjgh-2025-020891 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevance. doi:10.1128/jcm.01561-25 2026
Can we optimise the TB response amid funding constraints using evidence-based, cost-effective strategies. doi:10.5588/ijtldopen.25.0771 2026
Negating neglect: social scientific contributions on Neglected Tropical Diseases and global health. doi:10.1186/s12939-026-02824-z 2026
Overcoming barriers, driving progress: Clinical science at IAS 2025. doi:10.1002/jia2.70088 2026
104 records returned by the alias sweep (a separate sweep from the 83 above; both are shown, neither is exhaustive)

Searched as: Rv3375, amiD, Mb3409, MMAR_0984, MSMEG_1090 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Priority-setting in TB programme planning: guiding an equitable and effective response. doi:10.5588/ijtldopen.26.0258 IJTLD Open 2026
Implementation of differentiated service delivery strategies for patients with tuberculosis in Haiti during a severe humanitarian crisis, January-August 2021. doi:10.1371/journal.pgph.0006209 PLOS Glob Public Health 2026
Infectious complications in kidney transplant recipients across Africa: a scoping review of epidemiology, microbiology, and prophylaxis strategies. doi:10.1186/s12879-026-14052-5 BMC Infect Dis 2026
Divergent urban-rural drivers of malaria vector ecology: a 6-year One Health longitudinal study in China. doi:10.1186/s13071-026-07507-w Parasit Vectors 2026
Prioritising communicable disease research in Afghanistan: an application of the Child Health and Nutrition Research Initiative (CHNRI) methodology. doi:10.1136/bmjgh-2025-020891 BMJ Glob Health 2026
Prioritising in a crisis: what next for malaria research? doi:10.1186/s12936-026-05922-z Malar J 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevance. doi:10.1128/jcm.01561-25 J Clin Microbiol 2026
Can we optimise the TB response amid funding constraints using evidence-based, cost-effective strategies. doi:10.5588/ijtldopen.25.0771 names it IJTLD Open 2026
Negating neglect: social scientific contributions on Neglected Tropical Diseases and global health. doi:10.1186/s12939-026-02824-z Int J Equity Health 2026
Overcoming barriers, driving progress: Clinical science at IAS 2025. doi:10.1002/jia2.70088 J Int AIDS Soc 2026
Amikacin exposure in MDR-TB patients in Uganda: Revisiting old drugs in a new era of resistance - A pharmacokinetic assessment. doi:10.1016/j.nmni.2026.101734 New Microbes New Infect 2026
National and subnational burden of XDR-TB in China, 1990-2023: Long-term trends, regional disparities, and projections, 2024-2050. doi:10.1016/j.jinf.2026.106728 J Infect 2026
Clinical utility of lung biopsy in fibrotic interstitial lung disease. doi:10.1093/ajrccm/aamaf123 Am J Respir Crit Care Med 2026
Gender-responsive and -transformative interventions in HIV, TB and malaria programmes: a review of evidence. doi:10.1186/s12889-026-26622-y BMC Public Health 2026
Nutritional interventions for TB: a critical component of integrated TB care amid funding challenges. doi:10.5588/ijtld.25.0655 names it Int J Tuberc Lung Dis 2026
Successful Management of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis Amid Corticosteroid Constraints and Clinical-Biomarker Dissociation. doi:10.1016/j.jaccas.2025.106787 names it JACC Case Rep 2026
Sustainable solutions to protect tuberculosis control amid donor funding cuts. doi:10.1016/S2214-109X(25)00442-5 names it Lancet Glob Health 2026
Future Research Directions on Mycobacterium tuberculosis Proteins. doi:10.1007/978-3-031-96883-9_11 Adv Exp Med Biol 2026
Task sharing for point-of-care testing: Review of national health policies and implementation landscape in 19 African countries. doi:10.1371/journal.pgph.0005485 PLOS Glob Public Health 2025
A Narrative Review of Tuberculosis and Diabetes Mellitus: The Double Burden Epidemiology, the Current Moment and the Future. doi:10.7759/cureus.96016 Cureus 2025
Global excess tuberculosis mortality during COVID-19: a country-level modeling study of policy and development correlates. doi:10.1186/s12889-025-24858-8 BMC Public Health 2025
Tuberculosis in the Americas: a worsening crisis amid genomic surveillance gaps. doi:10.1016/j.lana.2025.101267 names it Lancet Reg Health Am 2025
Coordinated responses to maintain tuberculosis care amid climate emergencies: challenges and perspectives based on the events of Brazil. doi:10.1136/bmjgh-2025-019123 names it BMJ Glob Health 2025
Human CD4+ T cells recognize Mycobacterium tuberculosis-infected macrophages amid broader responses. doi:10.1084/jem.20250460 names it J Exp Med 2025
In search of a better tuberculosis governance in village level: A regulatory analysis in Indonesia. doi:10.1016/j.ijtb.2025.03.013 Indian J Tuberc 2025
Barriers to Care Leading to Fatal Consequences: A Case of Tuberculosis Sepsis Amid Policy Change. doi:10.7759/cureus.88918 names it Cureus 2025
Global blind spots in TB control - the need to focus on deprived urban neighbourhoods. doi:10.5588/ijtld.25.0196 Int J Tuberc Lung Dis 2025
Epidemiology and transmission dynamics of tuberculosis among internal migrants in Hangzhou: A retrospective analysis from 2013 to 2022. doi:10.1016/j.tmaid.2025.102875 Travel Med Infect Dis 2025
Tracking development assistance for health, 1990-2030: historical trends, recent cuts, and outlook. doi:10.1016/S0140-6736(25)01240-1 Lancet 2025
Systemic Sclerosis-Related Interstitial Lung Disease Amid Latent Tuberculosis and Recurrent Infections. doi:10.7759/cureus.87826 names it Cureus 2025
Strong antibody reactivity to HIV-1 synthetic peptides in seropositive indigenous Warao people. doi:10.7705/biomedica.7510 Biomedica 2025
Sudan's tuberculosis response needs global support amid conflict. doi:10.1016/S0140-6736(25)01119-5 names it Lancet 2025
The global TB portfolio model: a tool for projecting the epidemiological impact of TB policy options. doi:10.1101/2025.05.17.25327819 medRxiv 2025
Analysis of the impact of crises tuberculosis incidence in Ukraine amid pandemics and war. doi:10.1038/s41598-025-01723-7 names it Sci Rep 2025
The interplay of tuberculosis and COVID-19: Insights into global health challenges. J Biosci 2025
Clinical presentation of pediatric tuberculous spondylitis in high TB burden setting before and during the COVID-19 pandemic. doi:10.3855/jidc.20075 J Infect Dev Ctries 2025
Human memory CD4(+) T-cells recognize Mycobacterium tuberculosis-infected macrophages amid broader pathogen-specific responses. doi:10.1101/2025.02.23.639515 names it bioRxiv 2025
Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness: insights from a cross-country qualitative study with policy-makers in India, Indonesia and Nigeria. doi:10.1136/bmjgh-2024-016180 BMJ Glob Health 2025
Nano Revolution: Harnessing Nanoparticles to Combat Antibiotic-resistant Bacterial Infections. doi:10.2174/0113816128337749241021084050 Curr Pharm Des 2025
Paediatric Spina Ventosa: tuberculous dactylitis of the thumb can be a mislaid differential diagnosis - case report. doi:10.62347/WOUV4312 Am J Transl Res 2024
Enhancement of mycobacterial pathogenesis by host interferon-γ. doi:10.1007/s00018-024-05425-7 Cell Mol Life Sci 2024
Metabolic insights into HIV/TB co-infection: an untargeted urinary metabolomics approach. doi:10.1007/s11306-024-02148-5 Metabolomics 2024
Tuberculosis in the United States: A Worrisome New Trend Amid Nearly 30 Years of Continued Decline. doi:10.3928/19382359-20240507-01 names it Pediatr Ann 2024
The introduction of video-enabled directly observed therapy (video-DOT) for patients with drug-resistant TB disease in Eswatini amid the COVID-19 pandemic - a retrospective cohort study. doi:10.1186/s12913-024-11151-4 names it BMC Health Serv Res 2024
Long COVID-19 leading to Good's syndrome diagnosis: A clinical case-report and literature review. doi:10.1002/ccr3.8962 Clin Case Rep 2024
Individual- and Herd-Level Milk ELISA Test Status and Incidence for Paratuberculosis in Hubei Province, China. doi:10.3390/vetsci11050202 Vet Sci 2024
Fate and preservation of the late pleistocene cave bears from Niedźwiedzia Cave in Poland, through taphonomy, pathology, and geochemistry. doi:10.1038/s41598-024-60222-3 Sci Rep 2024
Understanding the Landscape of Bronchoscopy in Lung Cancer: Insights From Lesion Location, Gender, and Diagnostic Efficacy. doi:10.7759/cureus.53918 Cureus 2024
An Update to Novel Therapeutic Options for Combating Tuberculosis: Challenges and Future Prospectives. doi:10.2174/0113892010246389231012041120 Curr Pharm Biotechnol 2024
Sustained high fatality during TB therapy amid rapid decline in TB mortality at population level: A retrospective cohort and ecological analysis from Shiselweni, Eswatini. doi:10.1111/tmi.13961 names it Trop Med Int Health 2024
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa. doi:10.7196/SAMJ.2023.v113i11.497 S Afr Med J 2023
Longitudinal detection of subcategorized CD44v6(+) CTCs and circulating tumor endothelial cells (CTECs) enables novel clinical stratification and improves prognostic prediction of small cell lung cancer: A prospective, multi-center study. doi:10.1016/j.canlet.2023.216337 Cancer Lett 2023
Giant Cells of Various Lesions Are Characterised by Different Expression Patterns of HLA-Molecules and Molecules Involved in the Cell Cycle, Bone Metabolism, and Lineage Affiliation: An Immunohistochemical Study with a Review of the Literature. doi:10.3390/cancers15143702 Cancers (Basel) 2023
Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review. doi:10.1002/jia2.26110 J Int AIDS Soc 2023
Importance of Balanced Attention Toward Coronavirus Disease 2019 and Neglected Tropical Diseases. doi:10.3349/ymj.2022.0656 Yonsei Med J 2023
The impact of COVID-19 on TB in Iran: An illustrative study. doi:10.1016/j.jctube.2023.100357 J Clin Tuberc Other Mycobact Dis 2023
Structural basis for bacterial energy extraction from atmospheric hydrogen. doi:10.1038/s41586-023-05781-7 Nature 2023
Limited effect of reducing pulmonary tuberculosis incidence amid mandatory facial masking for COVID-19. doi:10.1186/s12931-023-02365-x names it Respir Res 2023
Falling through the cracks: Increased vulnerability and limited social assistance for TB patients and their households during COVID-19 in Cape Town, South Africa. doi:10.1371/journal.pgph.0000708 PLOS Glob Public Health 2022
Rapid and Accurate Discrimination of Mycobacterium abscessus Subspecies Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Spectrum and Machine Learning Algorithms. doi:10.3390/biomedicines11010045 Biomedicines 2022
Tuberculosis (TB) care challenges in post-conflict settings: The case of Afghanistan. doi:10.1016/j.ijtb.2022.03.002 Indian J Tuberc 2022
Fate, toxicity and effect of triclocarban on the microbial community in wastewater treatment systems. doi:10.1016/j.jhazmat.2022.129796 J Hazard Mater 2022
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. doi:10.5339/qmj.2022.29 Qatar Med J 2022
Public health crises and Ukrainian refugees. doi:10.1016/j.bbi.2022.05.004 Brain Behav Immun 2022
Surge of HIV, tuberculosis and COVID feared amid war in Ukraine. doi:10.1038/d41586-022-00748-6 names it Nature 2022
V-shaped recovery of tuberculosis notification trend amid COVID-19: Is it enough? doi:10.4103/lungindia.lungindia_653_21 names it Lung India 2022
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic. doi:10.3389/fimmu.2022.833715 Front Immunol 2022
Tobacco industry corporate social responsibility activities amid COVID-19 pandemic in India. doi:10.1136/tobaccocontrol-2020-056419 names it Tob Control 2022
Genomic characterization of variants on mycolic acid metabolism genes in Mycobacterium tuberculosis isolates from Santa Catarina, Southern Brazil. doi:10.1016/j.meegid.2021.105107 Infect Genet Evol 2021
Resurgence of tuberculosis amid COVID-19 in Peru: Associated risk factors and recommendations. doi:10.1002/hpm.3291 names it Int J Health Plann Manage 2021
Clinicopathological characteristics and aetiological factors of granulomatous gastritis. doi:10.1111/his.14462 Histopathology 2021
Association amid the comorbidity of Diabetes Mellitus in patients of Active Tuberculosis in Pakistan: A matched case control study. doi:10.12669/pjms.37.3.3274 names it Pak J Med Sci 2021
A Study of the Patient Acceptance Capacity of the Yamanashi Prefecture Medical System amid the Coronavirus Disease 2019 Pandemic. doi:10.31662/jmaj.2020-0034 names it JMA J 2021
Resource reprioritisation amid competing health risks for TB and COVID-19. doi:10.5588/ijtld.20.0566 names it Int J Tuberc Lung Dis 2020
BCG vaccine: a hope to control COVID-19 pandemic amid crisis. doi:10.1080/21645515.2020.1818522 names it Hum Vaccin Immunother 2020
Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages. doi:10.1089/AID.2019.0057 AIDS Res Hum Retroviruses 2020
Atypical Mycobacterial Infection Arising Amid Corticosteroid Therapy for Livedoid Vasculopathy. doi:10.1155/2019/1840280 names it Case Rep Dermatol Med 2019
Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya. doi:10.1371/journal.pone.0212972 PLoS One 2019
Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights. doi:10.4155/fmc-2017-0197 Future Med Chem 2018
Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections. doi:10.1002/adhm.201701395 Adv Healthc Mater 2018
Direct Electrochemical DNA Sensor based on a new redox oligomer modified with ferrocene and carboxylic acid: Application to the detection of Mycobacterium tuberculosis mutant strain. doi:10.1016/j.aca.2017.09.022 Anal Chim Acta 2017
A versatile vector for mycobacterial protein production with a functional minimized acetamidase regulon. doi:10.1002/pro.3288 Protein Sci 2017
Proteomics of Culture Filtrate of Prevalent Mycobacterium tuberculosis Strains: 2D-PAGE Map and MALDI-TOF/MS Analysis. doi:10.1177/2472555217717639 SLAS Discov 2017
Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria. doi:10.4314/ejhs.v27i2.3 Ethiop J Health Sci 2017
Low vaccination coverage of Greek Roma children amid economic crisis: national survey using stratified cluster sampling. doi:10.1093/eurpub/ckw179 names it Eur J Public Health 2017
Herd-level bovine tuberculosis risk factors: assessing the role of low-level badger population disturbance. doi:10.1038/srep13062 Sci Rep 2015
Tuberculosis vaccine development: Shifting focus amid increasing development challenges. doi:10.1080/21645515.2015.1040955 names it Hum Vaccin Immunother 2015
Diagnosis and treatment plan aims to eliminate TB across England. doi:10.7748/ns.29.22.10.s9 Nurs Stand 2015
Expression, purification and functional characterization of AmiA of acetamidase operon of Mycobacterium smegmatis. doi:10.1016/j.micres.2014.02.011 Microbiol Res 2014
Inhibition of spleen tyrosine kinase in the treatment of rheumatoid arthritis. doi:10.1093/rheumatology/ket225 Rheumatology (Oxford) 2013
Tuberculosis: current state of knowledge: an epilogue. doi:10.1111/resp.12156 Respirology 2013
Risk of tuberculosis in high-rise and high density dwellings: an exploratory spatial analysis. doi:10.1016/j.envpol.2012.11.025 Environ Pollut 2013
AIDS conference: encouraging advances amid funding worries for global treatment. doi:10.1001/jama.2010.1292 names it JAMA 2010
The multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stress. doi:10.1074/jbc.M110.135251 J Biol Chem 2010
Global tuberculosis control amid the world economic crisis. doi:10.1016/s1473-3099(09)70030-1 names it Lancet Infect Dis 2009
Identification and characterization of the regulatory elements of the inducible acetamidase operon from Mycobacterium smegmatis. doi:10.1139/W06-147 Can J Microbiol 2007
Inheriting vice, acquiring virtue: hereditary disease and moral hygiene in eighteenth-century France. doi:10.1353/bhm.2006.0141 Bull Hist Med 2006
An immunohistochemical, clinical and electroneuromyographic correlative study of the neural markers in the neuritic form of leprosy. doi:10.1590/s0100-879x2006000800010 Braz J Med Biol Res 2006
Pathology of naturally occurring paratuberculosis in water buffaloes (Bubalus bubalis). doi:10.1354/vp.43-4-455 Vet Pathol 2006
Control of the acetamidase gene of Mycobacterium smegmatis by multiple regulators. doi:10.1016/S0378-1097(03)00177-0 FEMS Microbiol Lett 2003
Thalidomide and tuberculosis. Int J Tuberc Lung Dis 2002
A preliminary survey for human immunodeficient virus (HIV) infections in tuberculosis and melioidosis patients in Ubon Ratchathani, Thailand. doi:10.7883/yoken1952.45.247 Jpn J Med Sci Biol 1992
[Epidemiologic surveillance of tuberculosis in French Polynesia between 1960 and 1990]. Bull Soc Pathol Exot 1992
[DIFFERENTIATION OF BOVINE AND AVIAN MYCOBACTERIA BY THE DETERMINATION OF NICOTINE-AND ISONICOTINAMIDASE ACTIVITY. (SHORT AMIDASE GROUP)]. Cesk Epidemiol Mikrobiol Imunol 1964

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

CRISPRi vulnerability

Vulnerability index 0.80 (95% CI -0.55 to 3.10). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.261 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=7 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in cellular metabolism [catalytic activity: a monocarboxylic acid amide + H(2)O = a monocarboxylate + NH(3)].
Mycobrowser EC 3.5.1.4 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3409 · 100.0% identity
M. marinum MMAR_0984 · 45.5% identity
M. smegmatis MSMEG_1090 · 35.2% identity
M. orygis RJtmp_003478 · 100.0% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WQ93 SwissProt · reviewed · Evidence at protein level
UniProt namePutative amidase AmiD
EC (curated) EC 3.5.1.4

As checked on 2026-09-23, UniProt listed this protein as Putative amidase AmiD; the revised annotation above goes beyond that record. UniProt may have been recurated since: check the live entry.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category J Translation, ribosomal structure and biogenesis
Preferred nameamiD
eggNOG descriptionCOG0154 Asp-tRNAAsn Glu-tRNAGln amidotransferase A subunit and related amidases
Orthologous groupCOG0154
EC number EC 3.5.1.4, EC 6.3.5.6, EC 6.3.5.7
KEGG orthology K01426, K02433
KEGG pathways map00330, map00360, map00380, map00627, map00643, map00970, map01100, map01120
Gene Ontology (8) GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0044424, GO:0044444, GO:0044464

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.422 · purifying
Polymorphic sites (≥ 0.1% of strains) 5 synonymous, 6 missense, 0 nonsense, 1 frameshift
Disruption 1 distinct premature-stop/frameshift site(s); most common in 0.20% of strains (282) · clonal

Read the disruption percentage against its ceiling, not against 100%. The strain collection is deeply imbalanced by clade, so a loss fixed in an entire lineage still shows a small overall fraction: a gene disrupted in every L6 strain caps at 0.96% of the collection, in every M. caprae strain at 0.20%, in every M. microti strain at 0.02%. Of the 705 clades in this collection, 689 have a ceiling below 1%. A figure of "0.15% of strains" is therefore uninterpretable on its own — it can be noise or a complete, lineage-defining loss. Use the clade attribution row above, which gives the sub-clade sizes, and never read the percentage alone.

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 1 consensus substitution(s)
low power (1 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 52/53 (98%) · mean identity 42.1% · 4/4 closest MTBAP relatives
conserved across the genus (present in 52/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 12/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 32.7%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 22 in the ORF — 0 in the essential state, 0 growth-defect, 22 non-essential, 0 growth-advantage. Saturation 0.909, mean read count 46.95. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 22 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB)

Conditionlog2FCqEffect
Differential genetic requirements of clinical Mtb strain (ID=621) from East Asian lineage (compared to H37Rv control) (strain background) +2.070.047 required
Differential genetic requirements of clinical Mtb strain (ID=662) from East Asian lineage (compared to H37Rv control) (strain background) +1.890.023 required

Conditional fitness of transposon-disruption mutants across 2 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 13 of 16 independent MS datasets
Integrated abundance14.0 ppm · rank 2527/3519 (28.2th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length475 aa
Molecular weight50.6 kDa
Theoretical pI5.55
GRAVY0.019 (hydrophobic)
Aliphatic index88.8
Aromaticity0.063
Instability index36.9 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
AmidasePF01425.27 3.3e-12138–455 Amidase

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 96.3, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 96.3

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
3h0l-assembly1_A 1.00 0.89 0.89 0.89 28% 97% / 100% 1.1e-38 sig 3h0l-assembly1_A Structure of trna-dependent amidotransferase gatcab from aquifex aeolicus
4wj3-assembly2_D 1.00 0.90 0.90 0.89 32% 96% / 99% 6.6e-38 sig 4wj3-assembly2_D Crystal structure of the asparagine transamidosome from Pseudomonas aeruginosa
2df4-assembly1_A 1.00 0.90 0.90 0.89 30% 95% / 98% 4.2e-36 sig 2df4-assembly1_A Structure of tRNA-Dependent Amidotransferase GatCAB complexed with Mn2+
6c62-assembly1_A 1.00 0.92 0.88 0.92 31% 96% / 100% 2.8e-36 sig 6c62-assembly1_A An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme.
6c6g-assembly1_B-2 1.00 0.91 0.87 0.91 30% 94% / 99% 1.1e-34 sig 6c6g-assembly1_B-2 An unexpected vestigial protein complex reveals the evolutionary origins of an s-triazine catabolic enzyme. Inhibitor bound complex.

Foldseek search of the AlphaFold DB model (mean pLDDT 96.3, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)echA18 (+ strand, 253 bp gap)
Downstream (3' on genome)Rv3376 (+ strand, 107 bp gap)

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3485) exponential phase: operon of 3, Rv3372 · Rv3375 (coverage 12.96)
not expressed (stationary phase) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv3736 (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: gatB (aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B), high confidence (score 969, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 58 partners at medium confidence (11 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 58 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3009c gatB exp (transferred) aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B 980 969 ctx cooccurence:774 coexpression:646 experimental:629 textmining:411
Rv2922A acyP curated acylphosphatase 903 904 database:900
Rv3012c gatC exp (transferred) glutamyl-tRNA(GLN) amidotransferase subunit C 913 903 coexpression:649 experimental:629
Rv3551 curated CoA-transferase subunit alpha 901 901 database:900
Rv3374 echA18.1 Probable enoyl-CoA hydratase EchA18.1 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase); Rv3374, (MTV004.32), len: 82 aa. Probabl 931 808 ctx neighborhood:799 textmining:654
Rv3373 echA18 enoyl-CoA hydratase 902 805 ctx neighborhood:799 textmining:519
Rv3293 pcd curated piperideine-6-carboxylic acid dehydrogenase 676 664 database:650
Rv0768 aldA curated aldehyde dehydrogenase AldA 673 661 database:650
Rv0223c curated aldehyde dehydrogenase 672 660 database:650
Rv0147 curated aldehyde dehydrogenase 671 659 database:650
Rv2572c aspS exp (transferred) aspartate--tRNA ligase 727 633 experimental:405
Rv2992c gltS exp (transferred) glutamate--tRNA ligase 697 604 experimental:549
Rv3376 phosphatase 823 541 ctx neighborhood:532 textmining:630
Rv2029c pfkB 6-phosphofructokinase PfkB 516 515 coexpression:513
Rv1379 pyrR bifunctional pyrimidine operon regulatory protein/uracil phosphoribosyltransferase 522 510 coexpression:430

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: amidase
  • MTBC0 PGAP product: amidase
  • Pfam (hmmscan --cut_ga): Amidase PF01425.27 (E=3e-121)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_217892.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Amidase (PF01425.27)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0154
  • Curated reference: UniProt P9WQ93 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 96.3)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 58 functional partner(s); context anchor gatB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003590|Rv3375|amiD
MTDADSAVPPRLDEDAISKLELTEVADLIRTRQLTSAEVTESTLRRIERLDPQLKSYAFVMPETALAAARAADADIARGHYEGVLHGVPIGVKDLCYTVDAPTAAGTTIFRDFRPAYDATVVARLRAAGAVIIGKLAMTEGAYLGYHPSLPTPVNPWDPTAWAGVSSSGCGVATAAGLCFGSIGSDTGGSIRFPTSMCGVTGIKPTWGRVSRHGVVELAASYDHVGPITRSAHDAAVLLSVIAGSDIHDPSCSAEPVPDYAADLALTRIPRVGVDWSQTTSFDEDTTAMLADVVKTLDDIGWPVIDVKLPALAPMVAAFGKMRAVETAIAHADTYPARADEYGPIMRAMIDAGHRLAAVEYQTLTERRLEFTRSLRRVFHDVDILLMPSAGIASPTLETMRGLGQDPELTARLAMPTAPFNVSGNPAICLPAGTTARGTPLGVQFIGREFDEHLLVRAGHAFQQVTGYHRRRPPV